Attention deficit hyperactivity disorder (ADHD) is among the most frequently reported coexisting psychiatric conditions in children with encopresis. Some case reports state that atomoxetine-a selective presynaptic norepinephrine reuptake inhibitor-approved for treatment of ADHD is also effective in the treatment of coexisting encopresis. Contrasting those reports, here we present a case diagnosed with ADHD and secondary encopresis without constipation whose encopretic symptoms increased after atomoxetine treatment and discuss possible mechanisms.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/WNF.0000000000000163 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of Ziziphus jujube Mill. Syrup versus polyethylene glycol in children with functional constipation: a randomized clinical trial.
Sci Rep
January 2025
Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Functional constipation is a common disorder of the gastrointestinal tract in children without specific treatment. Ziziphus jujuba has been used in traditional medicine for various diseases such as constipation. A safe and inexpensive treatment with few side effects can be used as an effective alternative to current medications.
View Article and Find Full Text PDFBiofeedback rehabilitation in children with encopresis due to retentive constipation using simple tools: a real-world study in a French paediatric centre.
BMJ Paediatr Open
December 2024
Pediatric Gastroenterology and Nutrition, Necker Enfants Malades Hospital, AP-HP, Paris, France.
This study aimed to describe the effectiveness of biofeedback (BFB) rehabilitation in children with retentive encopresis (RE). A retrospective, single-institution study was conducted in children with BFB sessions for RE between 2017 and 2020. Manometry data and associated envy scores were analysed.
View Article and Find Full Text PDFNeurodevelopmental predictors of treatment response in schizophrenia and bipolar disorder.
Psychol Med
October 2024
Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Paris, France.
Background: Treatment resistance is a major challenge in psychiatric disorders. Early detection of potential future resistance would improve prognosis by reducing the delay to appropriate treatment adjustment and recovery. Here, we sought to determine whether neurodevelopmental markers can predict therapeutic response.
View Article and Find Full Text PDFDeep representation learning from electronic medical records identifies distinct symptom based subtypes and progression patterns for COVID-19 prognosis.
Int J Med Inform
November 2024
School of Computer and Information Technology, Beijing Jiaotong University, China. Electronic address:
Article Synopsis
- The study examines symptom phenotypes of COVID-19 patients to identify subtypes with different outcomes and prognoses for better management of the disease.
- It analyzes 14,139 electronic medical records from Hubei Province, employing deep learning and clustering algorithms to classify patients into three distinct subtypes based on their symptoms.
- The identified subtypes reveal significant differences in prognosis, with Subtype 0 showing the highest mortality rate (4.72%) and specific symptom patterns that may help forecast patient outcomes.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!